Company · CIK 0001401040 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
DiaMedica Therapeutics Inc. · DMAC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 AForm 4 → | Aug 12, 4:23 pm EDT | Dietrich John PaulsPresident & CEO, Director | 60,200 | — | — | 128,791 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 AForm 4 → | Jun 3, 5:28 pm EDT | Randall Michael GiuffreDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:27 pm EDT | Richard KuntzDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:27 pm EDT | Daniel J. O'ConnorDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:26 pm EDT | Tanya LewisDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:26 pm EDT | Charles Pauling SembaDirector | 40,412 | — | — | 40,412 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:24 pm EDT | James T. ParsonsDirector | 51,189 | — | — | 51,189 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:23 pm EDT | Dietrich John PaulsPresident & CEO, Director | 380,000 | — | — | 380,000 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:23 pm EDT | Scott KellenCFO & Secretary | 162,000 | — | — | 162,000 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 5:22 pm EDT | Julie KropChief Medical Officer | 67,500 | — | — | 67,500 | — |